These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3392242

  • 21. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA, Buckley MM.
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [Abstract] [Full Text] [Related]

  • 22. Design, synthesis and biological activity of a series of torasemide derivatives, potent blockers of the Na+ 2Cl- K+ co-transporter: in-vitro study.
    Masereel B, Lohrmann E, Schynts M, Pirotte B, Greger R, Delarge J.
    J Pharm Pharmacol; 1992 Jul; 44(7):589-93. PubMed ID: 1357140
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.
    Lesne M, Clerckx-Braun F, Duhoux P, van Ypersele de Strihou C.
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):382-7. PubMed ID: 7118326
    [Abstract] [Full Text] [Related]

  • 24. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Kido H, Ohtaki Y.
    Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
    [Abstract] [Full Text] [Related]

  • 25. Failure of indomethacin to impair the diuretic and natriuretic effects of the loop diuretic torasemide in healthy volunteers.
    van Ganse E, Douchamps J, Deger F, Staroukine M, Verniory A, Herchuelz A.
    Eur J Clin Pharmacol; 1986 Aug; 31 Suppl():43-7. PubMed ID: 3536531
    [Abstract] [Full Text] [Related]

  • 26. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
    Dodion L, Ambroes Y, Lameire N.
    Eur J Clin Pharmacol; 1986 Aug; 31 Suppl():21-7. PubMed ID: 3780837
    [Abstract] [Full Text] [Related]

  • 27. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
    Reyes AJ, Leary WP.
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
    [Abstract] [Full Text] [Related]

  • 28. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure.
    Fliser D, Schröter M, Neubeck M, Ritz E.
    Kidney Int; 1994 Aug; 46(2):482-8. PubMed ID: 7967362
    [Abstract] [Full Text] [Related]

  • 29. Tubular effects of the diuretic torasemide.
    Lohrmann E, Burhoff I, Greger R.
    Cardiology; 1994 Aug; 84 Suppl 2():135-42. PubMed ID: 7954536
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological classification and renal actions of diuretics.
    Puschett JB.
    Cardiology; 1994 Aug; 84 Suppl 2():4-13. PubMed ID: 7954544
    [Abstract] [Full Text] [Related]

  • 31. Sites and mechanisms of action of diuretics in the kidney.
    Puschett JB.
    J Clin Pharmacol; 1981 Aug; 21(11):564-74. PubMed ID: 7338566
    [Abstract] [Full Text] [Related]

  • 32. Renal effects of the high ceiling diuretic torasemide in rats and dogs.
    Ghys A, Denef J, Delarge J, Georges A.
    Arzneimittelforschung; 1985 Aug; 35(10):1527-31. PubMed ID: 4074408
    [Abstract] [Full Text] [Related]

  • 33. Renal actions of piretanide and three other "loop" diuretics.
    McNabb WR, Noormohamed FH, Brooks BA, Lant AF.
    Clin Pharmacol Ther; 1984 Mar; 35(3):328-37. PubMed ID: 6697640
    [Abstract] [Full Text] [Related]

  • 34. Renal excretory profiles of loop diuretics: consequences for therapeutic application.
    Reyes AJ.
    J Cardiovasc Pharmacol; 1993 Mar; 22 Suppl 3():S11-23. PubMed ID: 7506333
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure.
    Kramer WG.
    Cardiology; 1994 Mar; 84 Suppl 2():108-14. PubMed ID: 7954532
    [Abstract] [Full Text] [Related]

  • 36. A sulphonylthiourea (BM 20) related to torasemide: a new loop diuretic with relative potassium-sparing properties.
    Masereel B, Schynts M, Krzesinski JM, Pirotte B, Rorive G, Delarge J.
    J Pharm Pharmacol; 1993 Aug; 45(8):720-4. PubMed ID: 7901370
    [Abstract] [Full Text] [Related]

  • 37. Clinical pharmacokinetics and pharmacodynamics of torasemide.
    Knauf H, Mutschler E.
    Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetic and pharmacodynamic studies of piretanide in rabbits. IV. Effect of piretanide on the proximal tubules and the loop of Henle under a hydrated condition.
    Lu W, Kakemi M, Koizumi T.
    J Pharmacobiodyn; 1988 Dec; 11(12):794-800. PubMed ID: 3254977
    [Abstract] [Full Text] [Related]

  • 39. Urinary excretion profile of torasemide and its diuretic action in dogs.
    Sogame Y, Okano K, Hayashi K, Uchida T, Tsuda Y.
    J Pharm Pharmacol; 1996 Apr; 48(4):375-9. PubMed ID: 8794986
    [Abstract] [Full Text] [Related]

  • 40. Failure of the loop diuretic torasemide to improve renal function of hypoxemic vasomotor nephropathy in the newborn rabbit.
    Dubourg L, Drukker A, Guignard JP.
    Pediatr Res; 2000 Apr; 47(4 Pt 1):504-8. PubMed ID: 10759158
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.